Zobrazeno 1 - 10
of 79
pro vyhledávání: '"María Luisa Villanueva-Peñacarrillo"'
Autor:
Mariam El Assar, Javier Angulo, Marta Santos-Ruiz, Paola Moreno, Anna Novials, María Luisa Villanueva-Peñacarrillo, Leocadio Rodríguez-Mañas
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120479 (2015)
Insulin resistance (IR) is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular disease (CVD). On the other hand, amylin has long been related to IR. However the role of amylin in the vascula
Externí odkaz:
https://doaj.org/article/1f8f4ae7d2684338a511e2bec887f37d
Autor:
Joel Montane, Gema Alcarraz-Vizán, Anna Novials, Lisa Cadavez, Carlos Castaño, Montse Visa, Joan-Marc Servitja, María Luisa Villanueva-Peñacarrillo
Publikováno v:
The FASEB Journal. 29:2970-2979
The toxic effects of human islet amyloid polypeptide (IAPP) on pancreatic islets have been widely studied. However, much less attention has been paid to the physiologic actions of IAPP on pancreatic β cells, which secrete this peptide together with
Publikováno v:
Diabetologia. 61:2251-2251
Autor:
Mónica De la Fuente, Francisca Mulero, María Luisa Villanueva-Peñacarrillo, Alicia Acitores, Rashed Manassra, Pedro Esbrit, Daniel Lozano, Sergio Portal-Núñez
Publikováno v:
AGE. 35:383-393
An age-related bone loss occurs, apparently associated with the concomitant increase in an oxidative stress situation. However, the underlying mechanisms of age-related osteopenia are ill defined since these studies are time consuming and require the
Autor:
Veronica Sancho, Isabel Valverde, Paola Moreno, Alicia Acitores, María Luisa Villanueva-Peñacarrillo, Bernardo Nuche-Berenguer, Nieves González, Irene Gutiérrez-Rojas
Publikováno v:
Journal of Molecular Endocrinology. 48:37-47
Exendin-4 (Ex-4) mimics glucagon-like peptide-1 (GLP-1 or GCG as listed in the HUGO database), being anti-diabetic and anorectic, in stimulating glucose and lipid metabolism in extrapancreatic tissues. We studied the characteristics of Ex-4 and GLP-1
Autor:
Montse Visa, Irene Gutiérrez-Rojas, Willy Malaisse, Anna Novials, Alicia Acitores, Leocadio Rodríguez-Mañas, P. Moreno, Nieves González, Ramon Gomis, Isabel Valverde, Bernardo Nuche-Berenguer, M El Assar, María Luisa Villanueva-Peñacarrillo
Publikováno v:
Peptides. 32:2077-2085
Amylin is co-secreted with insulin, responds to the same stimuli, is anorectic, lowers body weight by reducing fat mass, and is proposed for diabetes treatment. We examined the effect of a 3-day constant infusion of close to physiological doses of am
Autor:
Daniel Lozano, María L. Mariñoso, Paola Moreno, Pedro Esbrit, María Luisa Villanueva-Peñacarrillo, Bernardo Nuche-Berenguer, Irene Gutiérrez-Rojas
Publikováno v:
Journal of Endocrinology. 209:203-210
Increased fat mass contributes to bone deterioration. Glucagon-like peptide 1 (GLP-1) and its related peptide exendin 1–39 amide (Ex-4), two lipid-lowering peptides, exert osteogenic effects in diabetic states. We examined the actions of 3-day admi
Autor:
Pedro Esbrit, María Luisa Villanueva-Peñacarrillo, Nieves González, Isabel Valverde, Paola Moreno, Bernardo Nuche-Berenguer, Alicia Acitores, Sergio Portal-Núñez, Ana López-Herradón
Publikováno v:
Journal of Cellular Physiology. 225:585-592
Glucagon-like peptide 1 (GLP-1) controls glucose metabolism in extrapancreatic tissues through receptors other than the pancreatic cAMP-linked GLP-1 receptor; also, GLP-1 induces an insulin- and PTH-independent bone anabolic action in insulin-resista
Autor:
Jesús Cancelas, José R. Caeiro, Bernardo Nuche-Berenguer, Sonia Dapía, María Luisa Villanueva-Peñacarrillo, Paola Moreno, Juan J. Haro-Mora, Pedro Esbrit
Publikováno v:
Calcified Tissue International. 84:453-461
It has been suggested that hormones released after nutrient absorption, such as glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide 2 (GLP-2), could be responsible for changes in bone resorption. However, information about the ro
Autor:
Luis Arnes, Bernardo Nuche-Berenguer, Isabel Valverde, María Luisa Villanueva-Peñacarrillo, Paola Moreno
Publikováno v:
Regulatory Peptides. 153:88-92
Exendin-4, like GLP-1, is insulinotropic, antidiabetic and glucoregulatory among other properties, which are thought to be exerted through the pancreatic GLP-1 receptor; exendin-4 is also an agonist of the GLP-1 stimulatory action upon liver and musc